| Ytd | 38.92% | |
| 1y | 23.56% |
| Open | Prev Close | 2.58 | Low | High | Mkt Cap | 184.59M | |||
| Vol | 4.19K | Avg Vol | 730.33K | EPS | -1.34 | P/E | -1.93 | Forward P/E | -1.42 |
| Beta | 0.90 | Short Ratio | 5.44 | Inst. Own | 99.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 2.88 | 200-d Avg | 2.39 | 1yr Est | 15.83 |
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCo
On Monday, 369 companies set new 52-week lows.